BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 18579244)

  • 1. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
    Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
    Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External beam radiotherapy for differentiated thyroid cancer.
    Meadows KM; Amdur RJ; Morris CG; Villaret DB; Mazzaferri EL; Mendenhall WM
    Am J Otolaryngol; 2006; 27(1):24-8. PubMed ID: 16360819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
    Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
    Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
    Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
    Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radiation therapy after incomplete resection of penile cancer.
    Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
    Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
    Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
    Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrathyroidal extension in well-differentiated thyroid cancer: macroscopic vs microscopic as a predictor of outcome.
    Hu A; Clark J; Payne RJ; Eski S; Walfish PG; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2007 Jul; 133(7):644-9. PubMed ID: 17638775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
    Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.